
Researchers zero in on therapeutic target for aggressive uterine cancer
A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma.
December 17, 2021 10:00 AM
A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma.